Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Encapsulating peritoneal sclerosis in Japan: prospective multicenter controlled study.

H Kawanishi1,

  • 1Akane-Foundation Tsuchiya General Hospital, Hiroshima, Japan. hidekawa@enjoy.ne.jp

Peritoneal Dialysis International : Journal of the International Society for Peritoneal Dialysis
|March 13, 2002
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Isolated Pulmonary Cryptococcosis Confused with Lung Tumor 5 Years After Kidney Transplantation: A Case Report.

Transplantation proceedings·2019
Same author

Lanthanum carbonate treatment of patients with hyperphosphatemia undergoing CAPD.

Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis·2008
Same author

Complementary use of peritoneal and hemodialysis: therapeutic synergies in the treatment of end-stage renal failure patients.

Kidney international. Supplement·2008
Same author

Genetic analysis of multifocal superficial urothelial cancers by array-based comparative genomic hybridisation.

British journal of cancer·2007
Same author

Dicoumarol potentiates cisplatin-induced apoptosis mediated by c-Jun N-terminal kinase in p53 wild-type urogenital cancer cell lines.

Oncogene·2006
Same author

The pathogenesis and therapeutic option of encapsulating peritoneal sclerosis.

The International journal of artificial organs·2005

The incidence of Encapsulating Peritoneal Sclerosis (EPS) in peritoneal dialysis patients is 0.77%. This serious complication increased with dialysis duration, with many cases developing after switching to hemodialysis.

Area of Science:

  • Nephrology
  • Clinical Medicine
  • Epidemiology

Background:

  • Encapsulating peritoneal sclerosis (EPS) is a severe complication associated with peritoneal dialysis.
  • Understanding the incidence and clinical course of EPS is crucial for patient management.

Purpose of the Study:

  • To determine the incidence of EPS in peritoneal dialysis patients.
  • To investigate the clinical features and mortality rates associated with EPS.

Main Methods:

  • A prospective, multicenter study involving pre-registered peritoneal dialysis patients in Japan.
  • Follow-up of 4 years to accurately observe the onset of EPS.

Main Results:

  • The incidence of EPS was 0.77% (0.81% censored) among 2216 registered patients.

Related Experiment Videos

  • EPS incidence increased with the duration of peritoneal dialysis.
  • 12 of 17 EPS patients developed the condition after switching to hemodialysis; 6 died within the survey period.

    • Conclusions:

    • The current incidence of EPS is 0.77%, with an expected increase over time.
    • Further long-term observation is needed to fully elucidate the incidence, etiology, and prognosis of EPS.